To identify the ligand for the activated IFN‐I signaling, we measured IFNα and ‐β levels in the conditioned medium from the DC of BM‐MSCs and cancer cells using enzyme‐linked immunosorbent assay (ELISA). The gene discussed is IFNA1; the disease is cancer.